Overall, these data suggest that ETHE1 negatively correlates with VEGF-A expression in CRC patients and the combination of low ETHE1 and high VEGF-A expression can serve as a more effective prognostic indicator for CRC patients. The gene discussed is VEGFA; the disease is colorectal carcinoma.